| Literature DB >> 32190096 |
Rengfei Shi1, Jin Zhang1, Biqing Fang1, Xiangyang Tian1, Yu Feng1, Zepeng Cheng1, Zhongyu Fu1, Jingjing Zhang1, Jiaxi Wu2.
Abstract
INTRODUCTION: Marathon, as a long-distance aerobic exercise, has become a fashionable or popular sport. However, little is known about the holistic metabolic changes occurring within the serum metabolome of athletes after the completion of a marathon.Entities:
Keywords: Exercise; Marathon; Metabolomics; Serum
Year: 2020 PMID: 32190096 PMCID: PMC7071712 DOI: 10.1186/s12986-020-00436-0
Source DB: PubMed Journal: Nutr Metab (Lond) ISSN: 1743-7075 Impact factor: 4.169
Changes of body weight and blood biochemical indexes before- and after-marathon
| Indexes | Before | After | |
|---|---|---|---|
| Body weight (kg) | 61.17 ± 8.27 | 60.69 ± 8.28 | |
| Creatine kinase (IU) | 352.39 ± 159.23 | 543.22 ± 284.16 | |
| Isoenzyme (CK-MB) (IU) | 20.33 ± 5.30 | 27.89 ± 7.77 | |
| Urea (mmol/L) | 4.94 ± 0.84 | 6.71 ± 1.12 | |
| C-reactive protein (mg/L) | 0.61 ± 0.21 | 0.78 ± 0.28 | |
| Homocysteine (μmol/L) | 14.96 ± 3.45 | 18.18 ± 9.19 | |
| Testosterone (nmol/L) | 14.81 ± 4.95 | 7.36 ± 4.08 | |
| Cortisol (nmol/L) | 411.56 ± 108.27 | 773.50 ± 92.01 |
Fig. 1Identification of discriminating biomarkers by metabolomics analysis. The PCA (a) and OPLS-DA (c) score plot are in negative ion mode. PCA (b) and OPLS-DA (d) score plot are in positive ion mode following marathon. Validation plot of 200 permutation tests for OPLS-DA model is built for negative (e) and positive ion mode (f) before and after marathon. The slope of R2 is greater than 0 and the intercept of Q2 on Y axis is less than 0.05, indicating a valid model
Fig. 2Summary of pathway analyses based on metabolomics data. a Heatmap clearly shows the relationship in potential biomarkers between before- and after-marathon serum samples. The Euclidean distance matrix for the quantitative value of the differential metabolites, and cluster the differential metabolites with the complete linkage method. The abscissa represents different experimental groups, the ordinate represents the comparison of the metabolites among different groups, and the color blocks at different positions represent the relative expression of the corresponding metabolites. b Bubble plot displays the increasing impact of the enrichment analysis of metabolic pathways, with key bubbles reflecting that the metabolic pathways were significantly altered by marathon
The significant variations in serum metabolite indexes before- and after-marathon groups
| Pathway | Metabolite name (pubchem ID) | before | after | |
|---|---|---|---|---|
| Ascorbate and aldarate metabolism | L-Threonate(983) | 1.5382 ± 0.2986 | 2.1988 ± 0.3328 | 5.79 × 10− 8 |
| myo-Inositol(2148) | 0.4216 ± 0.1516 | 0.7572 ± 0.2611 | 5.08 × 10− 5 | |
| D-galacturonic acid(2578) | 0.09 95 ± 0.0190 | 0.1950 ± 0.0649 | 7.66 × 10−6 | |
| L-Arabinono-1,4-lactone(6329) | 0.1846 ± 0.0616 | 0.3516 ± 0.1631 | 0.0005 | |
| Glyoxylate and dicarboxylate metabolism | Glyceric acid(378) | 0.2275 ± 0.0437 | 0.3689 ± 0.0944 | 5.69 × 10−6 |
| Mesaconic acid(812) | 0.0475 ± 0.0082 | 0.0759 ± 0.0133 | 1.47 × 10− 6 | |
| L-Malic acid | 0.0756 ± 0.0221 | 0.1285 ± 0.0408 | 4.22 × 10− 5 | |
| cis-Aconitate(1987) | 0.0242 ± 0.004 | 0.0399 ± 0.0078 | 4.56 × 10− 8 | |
| Phenylalanine metabolism | trans-cinnamate(1311) | 0.2978 ± 0.0600 | 0.4957 ± 0.1099 | 3.41 × 10− 7 |
| Vanillin(1396) | 0.1815 ± 0.1291 | 0.3046 ± 0.0986 | 0.0018 | |
| 4-Hydroxycinnamic acid(1726) | 0.2163 ± 0.0796 | 0.3401 ± 0.1022 | 9.07 × 10− 5 | |
| Carbon metabolism | Glyceric acid(378) | 0.2275 ± 0.0437 | 0.3689 ± 0.0944 | 5.70 × 10−6 |
| Mesaconic acid(812) | 0.0475 ± 0.0082 | 0.0759 ± 0.0133 | 1.47 × 10−8 | |
| L-Malic acid | 0.0756 ± 0.0221 | 0.1285 ± 0.0408 | 4.22 × 10− 5 | |
| ABC transporters | myo-Inositol(2148) | 0.4216 ± 0.1516 | 0.7572 ± 0.2611 | 5.08 × 10−5 |
| D-Sorbitol(2225) | 0.4259 ± 0.0923 | 0.2469 ± 0.0530 | 9.56 × 10−8 | |
| D-galacturonic acid(2578) | 0.0995 ± 0.0190 | 0.1950 ± 0.0649 | 7.66 × 10− 6 | |
| D-Biotin(5747) | 1.4304 ± 0.3142 | 0.8752 ± 0.1676 | 0.0007 | |
| Citrate cycle (TCA cycle) | Pyruvate(182) | 0.3757 ± 0.1574 | 0.8178 ± 0.4326 | 0.0005 |
| L-Malic acid | 0.0756 ± 0.0221 | 0.1285 ± 0.0408 | 4.22 × 10−5 | |
| cis-Aconitate(1987) | 0.0242 ± 0.004 | 0.0399 ± 0.0078 | 4.56 × 10−6 | |
| Pentose and glucuronate interconversions | Ribitol(1400) | 0.0573 ± 0.0158 | 0.0819 ± 0.0152 | 1.09 × 10−5 |
| D-galacturonic acid(2578) | 0.0995 ± 0.0190 | 0.1950 ± 0.0649 | 7.66 × 10−6 | |
| Galactose metabolism | myo-Inositol(2148) | 0.4216 ± 0.1516 | 0.7572 ± 0.2611 | 5.08 × 10−5 |
| D-Sorbitol(2225) | 0.2469 ± 0.0530 | 0.4259 ± 0.0923 | 9.56 × 10−8 | |
| Galactonic acid(2637) | 0.1232 ± 0.0333 | 0.1895 ± 0.0447 | 3.05 × 10−6 | |
| Alanine aspartate and glutamate metabolism | L-Asparagine(879) | 0.1203 ± 0.0102 | 0.0974 ± 0.0114 | 4.27 × 10−8 |
| N-Acetylaspartylglutamate(6623) | 0.0052 ± 0.0009 | 0.0075 ± 0.0011 | 3.18 × 10−9 | |
| Amino sugar and nucleotide suger metabolism | D-galacturonic acid(2578) | 0.0995 ± 0.0190 | 0.1950 ± 0.0649 | 7.66 × 10−6 |
| Glucosamine(2809) | 0.1950 ± 0.0319 | 0.1284 ± 0.0208 | 2.68 × 10−9 | |
| N-Acetylmannosamine(2874) | 0.0279 ± 0.0024 | 0.0341 ± 0.0048 | 3.45 × 10−5 | |
| 2-Oxocarboxylic acid metabolism | cis-Aconitate(1987) | 0.0242 ± 0.004 | 0.0399 ± 0.0078 | 4.56 × 10−8 |
| N-Acetyl-L-glutamate(2440) | 0.0158 ± 0.0025 | 0.0206 ± 0.0033 | 3.50 × 10−6 | |
| Central carbon metabolism in cancer | L-Asparagine(879) | 0.1203 ± 0.0102 | 0.0974 ± 0.0114 | 4.27 × 10−8 |
| L-Malic acid | 0.0756 ± 0.0221 | 0.1285 ± 0.0408 | 4.22 × 10−5 | |
| Pentose phosphate pathway | Pyruvate(182) | 0.3757 ± 0.1574 | 0.8178 ± 0.4326 | 0.0005 |
| Glyceric acid(378) | 0.2275 ± 0.0437 | 0.3689 ± 0.0944 | 5.70 × 10−6 | |
| Pyrimidine metabolism | Beta-Alanine(2102) | 0.1499 ± 0.0676 | 0.2418 ± 0.0799 | 0.0003 |
| Cytidine5’-monophosphate(7878) | 0.0597 ± 0.0470 | 0.1394 ± 0.0870 | 0.0018 | |
| Purine metabolism | Adenine(949) | 0.0192 ± 0.0060 | 0.0347 ± 0.0087 | 4.22 × 10−5 |
| Hypoxanthine(984) | 1.0917 ± 0.2040 | 1.7128 ± 0.6085 | 0.0005 | |
| L-Glutamine(1262) | 3.7482 ± 0.5189 | 3.4252 ± 0.4635 | 0.0029 | |
| Inosine(5198) | 0.4593 ± 0.3814 | 0.2995 ± 0.1637 | 9.31 × 10− 5 | |
| Caffeine metabolism | Theophylline(2152) | 0.5386 ± 0.5401 | 1.0722 ± 0.7971 | 0.0041 |
| Theobromine(2187) | 0.0432 ± 0.0463 | 0.0544 ± 0.0465 | 0.0025 | |
| Phenylalanine metabolism | 4-Hydroxycinnamic acid(1726) | 0.2163 ± 0.0796 | 0.3401 ± 0.1022 | 9.07 × 10−5 |
| L-Tyrosine(2870) | 0.0172 ± 0.0038 | 0.0198 ± 0.0031 | 0.0001 |
Fig. 3Correlations among exercise performance, fat%, VO2max, hemoglobin, and the serum metabolomic indicators
Fig. 4Correlations between serum testosterone and cortisol and metabolomic indicators